The U.S. News & World Report rankings of the best cancer hospitals for 2016 brought no great surprises. The top four cancer centers did not change from last year:
When the Genomic Data Commons opened June 6, the $20 million portal that consolidates NCI's datasets contained genomic information from 14,500 patients.
A measure that authorizes the FDA to mandate companies developing cancer drugs for adults to also study their products in children when there is a matching molecular target was introduced in the House and Senate earlier this week.
Alfred G. Knudson Jr., the creator of the “two-hit hypothesis,” and a director of the Institute for Cancer Research at Fox Chase Cancer Center, died July 10. He was 93.
The European Commission approved a variation to the marketing authorization for Kyprolis (carfilzomib) to include use in combination with dexamethasone alone for adult patients with multiple myeloma who have received at least one prior therapy. The extended indication marks the second approval for Amgen's Kyprolis by the EC in less than a year.
FDA granted 510(k) clearance to the HARMONIC HD 1000i ultrasonic surgical device, developed by Ethicon, for use in open and laparoscopic procedures. The shape of the device mimics a mechanical dissector, reducing the need to use a separate dedicated dissecting instrument, according to Ethicon. HARMONIC HD 1000i is designed for use in numerous procedures and […]
FDA granted seribantumab, also known as MM-121, a Fast Track designation for development in patients with heregulin-positive, locally advanced or metastatic non-small cell lung cancer, whose disease has progressed following immunotherapy. Merrimack Pharmaceuticals, the drug’s sponsor, is conducting the SHERLOC trial, a global clinical study of seribantumab in combination with docetaxel or pemetrexed in heregulin-positive […]
MARK SOCINSKI was named executive medical director of the Florida Hospital Cancer Institute. He will oversee the coordination of clinical cancer services for the Florida Hospital network. He will also be a member of the institute's Thoracic Oncology Program.
The House Appropriations Subcommittee on Labor-HHS marked up a bipartisan spending bill July 6 that gives NIH a $1.25 billion increase in the 2017 fiscal year.
Gilman's resignation enabled him to retain the most precious of all privileges: the ability to look at himself in the mirror.
